The local unit of Germany-based Stada Arzneimittel AG, said in a statement on Thursday that it has assumed full responsibility for the commercialization of the antibiotic Zinnat, blood pressure ...

When Sandoz paid $500 million to acquire the rights to sell GSK’s trio of established cephalosporin antibiotics—Zinnat, Zinacef and Fortum—in more than 100 markets around the world, it said ...